Eli Lilly & Co. will set up a S$42 million ($31 million) digital health innovation hub in Singapore, expanding its research ...

Indianapolis is “potentially interested in acquiring” the right of way for a future rail-to-trail conversion on the Craven ...

The Purchase Line School Board voted to join a class action lawsuit against pharmaceutical giant Eli Lilly on Monday night.

We're going to bring things back." Indianapolis-based drug maker Eli Lilly and Co. is among the businesses that stand to benefit most from improved ties between Indiana and Ireland. Lilly recently ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other S&P 500 stocks. As per AXA Investment Managers, the US dominated financial markets this ...

What would a Harris or Trump presidency mean for health care policy? Why did Eli Lilly’s Mounjaro and Zepbound sales miss expectations? And does Adam believe in ghosts? We talk about all that an ...

Singer-songwriter Gracie Abrams joins Swift for the home stretch on the road this weekend, as Swift wraps up the Eras Tour in the States with three back-to-back shows in Indianapolis, Indiana ...

INDIANAPOLIS (AP) — Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations. The drugmaker ...

Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE: LLY) has had a strong run this year, up more than 55%. However, the company's success goes back much further, with the ...

Indianapolis firefighters first responded to a general fire alarm at the location, near 10th Street and the Indianapolis Public Library downtown, around 9:35 p.m., the fire department said in a ...

Those who follow my work closely know that I have been a big fan of pharmaceutical firm Eli Lilly and Company (NYSE:LLY) for a little while now. My first article about the company, published in ...

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts. J&J evaluated its Tremfya in patients with low ...